BlackRock, Inc. 13D and 13G filings for Bio-Rad Laboratories, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
BLACKROCK INC BLK |
1,929,864 8.500% |
0 (Unchanged) |
Filing |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
BLACKROCK INC BLK |
1,929,864 8.500% |
463,638 (+31.62%) |
Filing |
| 2024-01-29 5:25 pm Sale |
2023-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO |
BLACKROCK INC BLK |
1,466,226 6.100% |
-116,087 (-7.34%) |
Filing |
| 2023-01-31 5:52 pm Sale |
2022-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO |
BLACKROCK INC BLK |
1,582,313 6.400% |
-185,768 (-10.51%) |
Filing |
| 2022-01-31 5:49 pm Sale |
2021-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO |
BLACKROCK INC BLK |
1,768,081 7.100% |
-124,255 (-6.57%) |
Filing |
| 2021-01-28 5:56 pm Sale |
2020-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO |
BLACKROCK INC BLK |
1,892,336 7.600% |
-426,716 (-18.40%) |
Filing |